IL-17 as a Potential Target for Modulating Airway Neutrophilia

E-ISSN： 1873-4286|8|20|1855-1861

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.20, 2002-09, pp. : 1855-1861

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extracellular matrix and airway smooth muscle interactions: a target for modulating airway wall remodelling and hyperresponsiveness?

By Tran Thai Halayko Andrew J.

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 7, 2007-07 ,pp. : 666-671

NRC Research Press

Access to resources Recommend Favorite

IL-17F, a target for anti-cytokine therapy

By Maitra Amarnath Gaffen Sarah L

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. : 453-458

Informa Healthcare

Access to resources Recommend Favorite

IL-35: a potential target for the treatment of atherosclerosis

By Huang Ying Lin Ying-Zhong Shi Ying Ji Qing-Wei

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 10, 2013-10 ,pp. : 793-795

Govi-Verlag

Access to resources Recommend Favorite

The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?

By Chiricozzi Andrea Saraceno Rosita Chimenti Maria Sole Guttman-Yassky Emma Krueger James G

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 513-525

Informa Healthcare

Access to resources Recommend Favorite